Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

Joannah Score, Claire Hidalgo-Curtis, Amy V. Jones, Nils Winkelmann, Alison Skinner, Daniel Ward, Katerina Zoi, Thomas Ernst, Frank Stegelmann, Konstanze Döhner, Andrew Chase, Nicholas C. P. Cross

Blood (2012) 119 (5): 1208–1213.

https://doi.org/10.1182/blood-2011-07-367243

Published: 2012

Includes: Supplemental data

Journal Articles

The JAK2 46/1 Haplotype Predisposes to Myeloproliferative Neoplasms Characterized by Diverse Mutations.

Nicholas C.P. Cross, PhD, FRCPath, Peter Campbell, MD, PhD, Philip A Beer, BM, MRCP, MRCPath, Susanne Schnittger, PhD, Alessandro M. Vannucchi, MD, Katerina Zoi, PhD, Melanie Percy, PhD, FRCPath, Mary Frances McMullin, Linda Scott, BSc, PhD, Richard T. Silver, MD, David Oscier, MD, Claire Harrison, MD, Anthony R. Green, FRCP, FRCPath, FMed, Sci, Andrew Chase, PhD

Blood (2009) 114 (22): 433.

https://doi.org/10.1182/blood.V114.22.433.433

Published: 2009

Journal Articles

Frequent Inactivating Mutations of TET2 and CBL Are Associated with Acquired Uniparental Disomy in Atypical Chronic Myeloid Leukemia and Related Disorders.

Thomas Ernst, MD, Andrew Chase, PhD, Claire Hidalgo-Curtis, PhD, Katerina Zoi, PhD, Christine Zoi, MD, Andreas Hochhaus, MD, Andreas Reiter, MD, William Vainchenker, MD, PhD, Francis Grand, PhD, Nicholas C.P. Cross, PhD

Blood (2009) 114 (22): 3258.

https://doi.org/10.1182/blood.V114.22.3258.3258

Published: 2009

Journal Articles

Cytogenetically Cryptic Tyrosine Kinase Fusion Genes Are Rare in Atypical Myeloproliferative Neoplasms: An Analysis by Targeted Array Comparative Genomic Hybridization

Thomas Ernst, MD, Andrew Chase, PhD, Francis Grand, PhD, Andreas Reiter, MD, Nicholas C.P. Cross, PhD

Blood (2008) 112 (11): 2791.

https://doi.org/10.1182/blood.V112.11.2791.2791

Published: 2008

Journal Articles

Development of V617F JAK2 Associated Myeloproliferative Neoplasms Is a Non-Random Event That Is Strongly Dependent on JAK2 Haplotype

Nicholas C.P. Cross, PhD, Amy V. Jones, BSc, Richard T. Silver, MD, David Oscier, MD, Georgia Metzgeroth, MD, Y. Lynn Wang, MD, PhD, Andrew Collins, PhD, Andreas Reiter, MD, Francis Grand, PhD, Andrew Chase, PhD

Blood (2008) 112 (11): 173.

https://doi.org/10.1182/blood.V112.11.173.173

Published: 2008

Journal Articles

Frequent CBL Mutations Associated with 11q Acquired Uniparental Disomy in Myeloproliferative Neoplasms

Francis Grand, PhD, Claire Hidalgo-Curtis, BSc, Thomas Ernst, MD, Katerina Zoi, PhD, Christine Zoi, MD, Carolann McGuire, PhD, Sebastian Kreil, MD, Georgia Metzgeroth, MD, David Oscier, MD, Andrew Hall, PhD, Christian Brandts, MD, Hubert Serve, Andreas Reiter, MD, Andrew Chase, PhD, Nicholas C.P. Cross, PhD

Blood (2008) 112 (11): 174.

https://doi.org/10.1182/blood.V112.11.174.174

Published: 2008

Journal Articles

Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome

Andrew Chase, Francis H. Grand, Nicholas C. P. Cross

Blood (2007) 110 (10): 3729–3734.

https://doi.org/10.1182/blood-2007-02-074286

Published: 2007

Journal Articles

Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia

Sebastian Kreil, Markus Pfirrmann, Claudia Haferlach, Katherine Waghorn, Andrew Chase, Rüdiger Hehlmann, Andreas Reiter, Andreas Hochhaus, Nicholas C. P. Cross

Blood (2007) 110 (4): 1283–1290.

https://doi.org/10.1182/blood-2007-02-074252

Published: 2007

Includes: Supplemental data

Journal Articles

TKI258 (CHIR-258) Selectively Inhibits FGFR1 Fusion Genes Associated with the 8p11 Myeloproliferative Syndrome.

Andrew Chase, Francis H. Grand, Nicholas C.P. Cross

Blood (2006) 108 (11): 2699.

https://doi.org/10.1182/blood.V108.11.2699.2699

Published: 2006

Journal Articles

Durable responses to imatinib in patients with PDGFRB fusion gene–positive and BCR-ABL –negative chronic myeloproliferative disorders

Blood (2006) 109 (1): 61–64.

https://doi.org/10.1182/blood-2006-05-024828

Published: 2006

Journal Articles

SPTBN1-FLT3 in Atypical Chronic Myeloid Leukemia Transforms Ba/F3 Cells to IL-3 Independence and Is Sensitive to Both Tyrosine Kinase Inhibitors and Immunotherapy.

Francis H. Grand, PhD, Sameena Iqbal, BSc, Lingyan Zhang, MD, Nigel H. Russell, MD, Andrew Chase, PhD, Nicholas C.P. Cross, PhD

Blood (2005) 106 (11): 2009.

https://doi.org/10.1182/blood.V106.11.2009.2009

Published: 2005

Journal Articles

Recurrent Fusion of PCM1 to JAK2 in Atypical Chronic Myeloid Leukemia and Acute Leukemia Associated with the t(8;9)(p21-22;p23-24).

Andreas Reiter, Christoph Walz, Ann Watmore, Claudia Schoch, Ilona Blau, Nick Telford, Shilani Aruliah, John Yin, Danny Vanstraelen, Helen Barker, Peter Taylor, Aisling O’Driscoli, Brigitte Schlegelberger, Ute Berger, Andreas Hochhaus, Rüdiger Hehlmann, Andrew Chase, Nicholas C.P. Cross

Blood (2004) 104 (11): 2963.

https://doi.org/10.1182/blood.V104.11.2963.2963

Published: 2004

Journal Articles

Factors affecting duration of survival after onset of blastic transformation of chronic myeloid leukemia

Jyoti Wadhwa, Richard M. Szydlo, Jane F. Apperley, Andrew Chase, Marco Bua, David Marin, Eduardo Olavarria, Edward Kanfer, John M. Goldman

Blood (2002) 99 (7): 2304–2309.

https://doi.org/10.1182/blood.V99.7.2304

Published: 2002

Journal Articles

Absence of host-derived cells in the blood of patients in remission after allografting for chronic myeloid leukemia

Andrew Chase, Sally Parker, Jaspal Kaeda, Renuka Sivalingam, Nicholas C. P. Cross, John M. Goldman

Blood (2000) 96 (2): 777–778.

https://doi.org/10.1182/blood.V96.2.777

Published: 2000

Journal Articles

Fusion of ETV6 to the Caudal-Related Homeobox Gene CDX2 in Acute Myeloid Leukemia With the t(12;13)(p13;q12)

Andrew Chase, Andreas Reiter, Linda Burci, Giovanni Cazzaniga, Andrea Biondi, Julie Pickard, Irene A.G. Roberts, John M. Goldman, Nicholas C.P. Cross

Blood (1999) 93 (3): 1025–1031.

https://doi.org/10.1182/blood.V93.3.1025

Published: 1999

Journal Articles

Consistent Fusion of ZNF198 to the Fibroblast Growth Factor Receptor-1 in the t(8;13)(p11;q12) Myeloproliferative Syndrome

Andreas Reiter, Jastinder Sohal, Shashikant Kulkarni, Andrew Chase, Donald H.C. Macdonald, Ricardo C.T. Aguiar, Cristina Gonçalves, Jesus M. Hernandez, Barbara A. Jennings, John M. Goldman, Nicholas C.P. Cross

Blood (1998) 92 (5): 1735–1742.

https://doi.org/10.1182/blood.V92.5.1735

Published: 1998

Journal Articles

Abnormalities of Chromosome Band 8p11 in Leukemia: Two Clinical Syndromes Can Be Distinguished on the Basis of MOZ Involvement

Ricardo C.T. Aguiar, Andrew Chase, Stephanie Coulthard, Donald H.C. Macdonald, Melina Carapeti, Andreas Reiter, Jastinder Sohal, Anne Lennard, John M. Goldman, Nicholas C.P. Cross

Blood (1997) 90 (8): 3130–3135.

https://doi.org/10.1182/blood.V90.8.3130

Published: 1997

NARROW

Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

The JAK2 46/1 Haplotype Predisposes to Myeloproliferative Neoplasms Characterized by Diverse Mutations.

Frequent Inactivating Mutations of TET2 and CBL Are Associated with Acquired Uniparental Disomy in Atypical Chronic Myeloid Leukemia and Related Disorders.

Cytogenetically Cryptic Tyrosine Kinase Fusion Genes Are Rare in Atypical Myeloproliferative Neoplasms: An Analysis by Targeted Array Comparative Genomic Hybridization

Development of V617F JAK2 Associated Myeloproliferative Neoplasms Is a Non-Random Event That Is Strongly Dependent on JAK2 Haplotype

Frequent CBL Mutations Associated with 11q Acquired Uniparental Disomy in Myeloproliferative Neoplasms

Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome

Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia

TKI258 (CHIR-258) Selectively Inhibits FGFR1 Fusion Genes Associated with the 8p11 Myeloproliferative Syndrome.

Durable responses to imatinib in patients with PDGFRB fusion gene–positive and BCR-ABL –negative chronic myeloproliferative disorders

SPTBN1-FLT3 in Atypical Chronic Myeloid Leukemia Transforms Ba/F3 Cells to IL-3 Independence and Is Sensitive to Both Tyrosine Kinase Inhibitors and Immunotherapy.

Recurrent Fusion of PCM1 to JAK2 in Atypical Chronic Myeloid Leukemia and Acute Leukemia Associated with the t(8;9)(p21-22;p23-24).

Factors affecting duration of survival after onset of blastic transformation of chronic myeloid leukemia

Absence of host-derived cells in the blood of patients in remission after allografting for chronic myeloid leukemia

Fusion of ETV6 to the Caudal-Related Homeobox Gene CDX2 in Acute Myeloid Leukemia With the t(12;13)(p13;q12)

Consistent Fusion of ZNF198 to the Fibroblast Growth Factor Receptor-1 in the t(8;13)(p11;q12) Myeloproliferative Syndrome

Abnormalities of Chromosome Band 8p11 in Leukemia: Two Clinical Syndromes Can Be Distinguished on the Basis of MOZ Involvement

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only